Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling-Reference-Cited by-同舟云学术

Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling

Published:2004-04-25 Issue:5 Volume:7 Page:501-509
ISSN:1097-6256
Container-title:Nature Neuroscience
language:en
Short-container-title:Nat Neurosci

Author:

Himanen Juha-Pekka,Chumley Michael J,Lackmann Martin,Li Chen,Barton William A,Jeffrey Phillip D,Vearing Christopher,Geleick Detlef,Feldheim David A,Boyd Andrew W,Henkemeyer Mark,Nikolov Dimitar B

Publisher

Springer Science and Business Media LLC

Subject

General Neuroscience

Link

http://www.nature.com/articles/nn1237.pdf

Reference42 articles.

1. Eph Nomenclature Committee. Unified nomenclature for Eph family receptors and their ligands, the Ephrins. Cell 90, 403–404 (1997).

2. Flanagan, J.G. & Vanderhaeghen, P. The ephrins and Eph receptors in neural development. Annu. Rev. Neurosci. 21, 309–345 (1998).

3. Frisen, J., Holmberg, J. & Barbacid, M. Ephrins and their Eph receptors: multitalented directors of embryonic development. EMBO J. 18, 5159–5165 (1999).

4. Kullander, K. & Klein, R. Mechanisms and functions of Eph and ephrin signalling. Nat. Rev. Mol. Cell Biol. 3, 475–486 (2002).

5. Henkemeyer, M. et al. Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell 86, 35–46 (1996).

Cited by 392 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A genome-wide association study of escitalopram treatment outcomes in patients with major depressive disorder;Gene;2024-10

2. Recent advances of the Ephrin and Eph family in cardiovascular development and pathologies;iScience;2024-08

3. Spatial-temporal comparison of Eph/Ephrin gene expression in ocular lenses from aging and knockout mice;Frontiers in Ophthalmology;2024-06-04

4. Enhanced EphB2-Specific Peptide Inhibitors through Stabilization of Polyproline II Helical Structure;ACS Chemical Biology;2024-05-13

5. An orally available compound suppresses glucagon hypersecretion and normalizes hyperglycemia in type 1 diabetes;JCI Insight;2024-01-23